(Q83014784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Kazuki Sakai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Eri Kawata

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Eishi Ashihara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yoko Nakagawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Akira Yamauchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hisayuki Yao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Rina Nagao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ruriko Tanaka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Asumi Yokota

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Miki Takeuchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hideyo Hirai

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Shinya Kimura

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mitsuomi Hirashima

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Norio Yoshimura

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Taira Maekawa

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

9 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

67-75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

Galectins: a family of animal beta-galactoside-binding lectins

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

God must love galectins; he made so many of them

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Regulation of galectin-9 expression and release in Jurkat T cell line cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Galectin-9 in physiological and pathological conditions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Galectin-9 induces maturation of human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

IL-17 contributes to CD4-mediated graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

'Green mice' as a source of ubiquitous green cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939931

7 January 2021

Identifiers

DOI

10.1002/EJI.200939931

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21182078%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference